Scholars Central

OtherPublished 7 Sep 2023

EXPLORING ADVERSE EVENTS OF REMDESIVIR IN COVID-19 PATIENTS: A COMPREHENSIVE GLOBAL ANALYSIS

Authors: Reza Akhavan-Sigari

Annals of Experimental Biology

Volume 11 · Issue 5 · Pages 157–167

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: The emergence of COVID-19, stemming from SARS-CoV-2, has triggered a globalpandemic, urging rapid therapeutic interventions. Remdesivir, a nucleotide analog prodrug, garneredattention for its potential against COVID-19 due to in vitro efficacy against coronaviruses. This studyreviews Remdesivir’s adverse effects in COVID-19 patients. Methodology: while remdesivir shows promise, recent studies raise efficacy concerns. adverse drug event (ade) documentation is vital due to limited pre-pandemic ade data. who vigibase® analysis (2015-2020) and covid-19 ade studies were undertaken, focusing on age, severity, region, and organ impact. 1086 ades emerged from 439 case reports by july 19, 2020, in vigibase®, reducing to 1004 after duplicates were removed. ades primarily related to covid-19 patients (92.5%), notably from the americas (67.7%). mainly in males above 45, ades were serious (82.5%). key ades encompassed elevated hepatic enzymes (32.1%), renal damage (14.4%), increased creatinine levels (11.2%), and respiratory failure (6.4%). Conclusion: Liver and kidney function deterioration emerged as frequent ADEs, underscoring the need for vigilance during Remdesivir treatment. These findings align with regulatory documents. In sum, COVID-19 has prompted swift therapeutic responses, with Remdesivir being explored as a potential treatment. This study sheds light on associated ADEs, highlighting the importance of monitoring and informed decision-making

Subjects

Biology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalAnnals of Experimental Biology
  • SubjectBiology
  • BylineArticles whose byline prints “Reza Akhavan-Sigari”